BRUSSELS, April 9 (Reuters) - Pharmaceutical compounding group Fagron is in talks to make acquisitions in Europe, the United States and Brazil, the group's chief executive said on Thursday.
The group, which sells in ingredients to pharmacists to make bespoke medicines, announced no acquisitions in the first quarter.
05:37 Rodrigo Duterte Says Donald Trump Endorses His Violent Antidrug Campaign6
03:00 Carrier incentives stir debate over 'rewarding' offshoring12
18:07 Trump’s deal to keep Carrier jobs in Indiana includes $7 million in state subsidies11
16:54 A Subdued Putin Calls for ‘Mutually Beneficial’ Relations With the U.S12